Navigation Links
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Date:11/29/2007

ABBOTT PARK, Ill., Nov. 29 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT)announced today that the Circulatory System Devices Advisory Panel to the U.S. Food and Drug Administration (FDA) recommended approval for the XIENCE(TM) V Everolimus Eluting Coronary Stent System. XIENCE V is a next-generation drug eluting stent intended for use in the treatment of coronary artery disease.

The FDA advisory committee voted to recommend the XIENCE V stent system for approval with conditions related to post-marketing study requirements and language related to dual antiplatelet therapy. The FDA is not required to, but usually follows the recommendations of its advisory committees.

"The clinical and angiographic benefits of the XIENCE V stent compared to the most widely used drug eluting stent available in the U.S. have been consistent and significant across the SPIRIT trials," said Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York and principal investigator of the SPIRIT III clinical trial. "The robust body of safety and efficacy data support approval of XIENCE V as an important new technology that will enhance the lives of millions of patients with heart disease."

Abbott filed its Premarket Approval (PMA) submission for XIENCE V with the FDA on June 1, 2007. The PMA for XIENCE V is the first to include data demonstrating superiority of one drug eluting stent over another in the primary endpoint of in-segment late loss in a randomized controlled head-to-head trial with a market leading product.

"The outcome of today's advisory committee meeting is very encouraging," said John M. Capek, Ph.D., executive vice president, Medical Products, Abbott. "We look forward to bringing this important new treatment for coronary artery disease to physicians and patients in the U.S."

XIENCE V was launched in Europe and other international markets in 2006. XIENCE V is currently an investigational
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Based ... GROUP is internationally known as an industry leader specializing in surplus used medical ... selling more than 100,000 pieces of medical equipment every year. Erik Tivin, Chairman ...
(Date:9/2/2015)... ... 2015 , ... “ G-Hold ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... a tablet while reducing the likelihood of it dropping. , Tablets like the iPad ...
(Date:9/2/2015)... NC (PRWEB) , ... September 02, 2015 , ... ... IT and business services, has been named to the Inc. 5000 List, an ... has been publishing this list for 34 years, and this achievement puts Canopy ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... Miami, FL (PRWEB) , ... September 01, 2015 ... ... Food and Drug Administration (FDA) for the treatment of androgenic alopecia in adults, ... the brand new laser therapy cap, while also demonstrating its safety when used ...
Breaking Medicine News(10 mins):Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... from around the world met at a conference in ... in obesity. One line of discussion looked at factors ... it might be avoided. , Co-chairs of the conference, ... Research and Dr Jennifer Lovejoy from the University of ...
... directed KH Real Estate to issue a boil water advisory to ... Armstrong County, after samples taken by DEP tested positive for fecal ... received complaints from residents after two customers were hospitalized with intestinal ... for the bacteria. , , ...
... NEW YORK, Nov. 24, 2008 Forest Laboratories, Inc. (NYSE: ... and Trademark Office ("USPTO") has closed prosecution on the merits ... confirmed the validity of all of the previously granted claims. ... Intent to Issue Ex Parte Reexamination Certificate for U.S. Patent ...
... treatment system for advanced radiation therapy, today announced that Rafael (Ralph) ... effective December 1, 2008. Mr. Vaello, who will report to TomoTherapy ... the sales and field marketing group for Philips Healthcare’s Oncology Imaging ... ...
... celebrity trainer Ramona Braganza offers tips to stay trim over the holidays and ... without packing on the pounds. , , ... trimmings: , , , ... before you load your plate for dinner or head out to a holiday ...
... of them currently abstain from alcohol, drugs , , MONDAY, ... Americans over the age of 12 participate in self-help ... 2.3 million who currently abstain from use of these ... Monday by the federal Substance Abuse and Mental Health ...
Cached Medicine News:Health News:Why women should eat less, move more and consider wearing transdermal HRT patches during menopause 2Health News:Pennsylvania DEP Directs Shadyside Water Supply to Issue Boil Water Advisory 2Health News:USPTO Confirms Validity of Bystolic(R) Patent 2Health News: TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries 2Health News:Tip Sheet: Celebrity Trainer, Ramona Braganza's Tips To Keep Off Those Extra Holiday Pounds 2Health News:5 Million People a Year Use Self-Help Addiction Programs 2
(Date:9/1/2015)... Sept. 1, 2015 On August 31, 2015, ... , issued a 123-page order in the first of ... Conserve metal-on-metal hip replacement devices are defective.[1]  ... as to Plaintiff Robyn Christiansen,s claims for defective design, ... flatly rejected Wright Medical,s claim that the Medical Device ...
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, ... termination of the option and license agreement for ... 2015. There was no payment associated with termination ... February 2014, Ardelyx and Sanofi entered into an ...
Breaking Medicine Technology:Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3
... Evergreen Healthcare Foundation raised nearly $1.1 million for Women,s ... of more than 700 guests of this evening,s 11th ... will support the organization,s commitment to provide women with ... The "Esplendor de Espana" gala brought together community ...
... MADISON, N.J., April 27, 2012  Quest Diagnostics (NYSE: ... testing, information and services, announced it has begun an ... secure 16 digit identification number – to every Quest ... largest effort of its kind in the area of ...
Cached Medicine Technology:Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center 2Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center 3Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date 2
... standard, corrected curve trial lenses are ground with ... Marco refractors and are invaluable in treating low ... other manufacturers contain a disproportionately large number of ... expensive to produce, and fewer lenses in the ...
The LM-990A is the most completely automatic lensemeter ever created. It even measured monocular and binocular PD automatically....
... has made the LM-770 the easiest ... Technicians can be trained to operate ... instruction. The instrument tells the user ... A flashing indicator alerts the user ...
... designed to perform precise and accurate ... one-third the space of traditional examinations. ... refractors, automatic or digital lensmeters and ... EPIC enables the operator to call ...
Medicine Products: